Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

Clinical trial NCT05354024 · COMPLETED

Trial details

NCT number: NCT05354024
Sponsor: Butantan Institute
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Coronavirus Infections Healthy

Start date: 2023-02-28
Primary completion: 2023-10-05
Enrollment: 4400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.